Share Name Share Symbol Market Type Share ISIN Share Description
Versarien LSE:VRS London Ordinary Share GB00B8YZTJ80 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 15.875p 15.50p 16.25p 15.875p 15.875p 15.875p 100,602 07:35:32
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Industrial Engineering 5.9 -2.2 -1.9 - 20.85

Versarien (VRS) Latest News

More Versarien News
Versarien Takeover Rumours

Versarien (VRS) Share Charts

1 Year Versarien Chart

1 Year Versarien Chart

1 Month Versarien Chart

1 Month Versarien Chart

Intraday Versarien Chart

Intraday Versarien Chart

Versarien (VRS) Discussions and Chat

Versarien (VRS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2017-08-18 14:39:2015.7585,00013,387.50OK
2017-08-18 11:42:3315.9915,6022,493.98O
View all Versarien trades in real-time

Versarien (VRS) Top Chat Posts

DateSubject
18/8/2017
09:20
Versarien Daily Update: Versarien is listed in the Industrial Engineering sector of the London Stock Exchange with ticker VRS. The last closing price for Versarien was 15.88p.
Versarien has a 4 week average price of 15.50p and a 12 week average price of 15.50p.
The 1 year high share price is 28p while the 1 year low share price is currently 9.25p.
There are currently 131,330,702 shares in issue and the average daily traded volume is 76,209 shares. The market capitalisation of Versarien is £20,848,748.94.
18/8/2017
14:33
festario: The KLF, I know what you meant. I used to work as a senior manager in a listed company. Share price was something never mentioned in any management meeting.Each Tuesday I had to attend the Directors meeting, and present the weeks stats. I never heard a director concern themselves with the share price, or shareholders ever.A decent company just gets on with the job and the share price responds accordingly.
06/8/2017
20:03
superg1: No JH as NDAs are not material on share price moves and therefore don't trigger an RNS. While you and I know if they put out a list of the multi £billion companies aims talking to them via news then it would very likely move the share price NDAs as said by the CEO are worthless. They become worth something when NDAs move to material MOUs JVs and the like. As the CEO said he could put out news every week about new collaborations but what is the point in that. I do note some do that but then some of those also lie in other news. They like hype. I did chuckle at one recently that compared their gains saying it was X amount better than current commercially available products. So if someone can show me a list what graphene related products are produced in bulk for worldwide sales for any product then I'd like to know. So no the Cambridge lot are not barred in any way the info is not material in nomad or company terms. Some do like to name them all though in news but that is up to them. It does help some that have no viable business in the short term but they will be found out in the end. At Cambridge we were also told (as I have said before) that Carbide had a new defence sales the first order of which had been paid for. Then another product for Aerospace where first supplies are expected Sept 17. I did discuss some of those and it was said in at least one case due to the underlying circs of how it came about (being vague there) that the company thought it should be in an RNS but the Nomad said no. It's a point I raise. There is no way the Nomad would want VRS telling PIs what lies behind that. If that were known and was slipped onto a BB then I'm sure the Nomad would rapidly change their mind and an RNS would appear. They like it both ways. One that they decide its not material and no rns but also that no one should be told even though they deem it not material. Why, because in some cases of lies underneath the share price could fly and then you have the same issue as an NDA if things don't fully materialise. So the it will be officially known who VRS are talking to is if one or more of them turns into something greater than a NDA, at which point probably is something to get excited about. I think nomads are very bad news for Aim companies and that rule should be abolished. After all they are wholly incompetent in identifying frauds. Th fact a nomad is there makes some think news must therefore be correct. Without names I think PIs would do a lot more of their own research and may not get sucked in so easily. As the MM said to me on investor day when I said 90% of nomads are bent. He corrected me saying 100% and he said so with a very stern look on his face. I haven't been tracking or invested in a share yet where I think the nomad is straight. Think of it this way nothing can get announced without going through the nomad first. So if a big name does end up as a deal the Nomad will know first. If you think inside info rules stops them and mates you'd be mistaken. I say that with great confidence having direct live experience of what they do at times.
02/8/2017
17:31
ridicule: John Henry I was the 108 seller at 10.10 today. I still have a substantial holding, but very few on here ever mention the lost 'opportunity cost' of trapped or dead money when a share languishes. I have mentioned the poor sales performance of VRS on this site several times over recent months; this has effectively stopped all the money invested here from working to create value over the period in question. I exited with a 16.83% profit on that holding this morning. This was achieved in less than 10 months. I have put the £18k to work elsewhere for a time where it can better earn its keep and possibly offset the dead money that I still have here because of the continued poor performance of the VRS share price due to lack of action. This is not trading Superg, its active investing. I still hold out hope for VRS which is why I still have a significant holding, Neill has not delivered sufficiently to stop me reducing at this stage however. As I see it, I can get back in in around 30 secs using 3 or 4 mouse clicks. I suspect the first signs of business breakthrough here will not be instantly transformational for the share price and I may be able to add at a lower price than today if matters remain as quiet here as they have over the last 9 months.
15/6/2017
10:24
rogerbridge: VRS have an incredible graphene portfolio but it does take time for new technologies to emerge in products. A comparison. I have another frustrating investment AGL, but by no means anywhere near the size as VRS. The technoliogy is brilliant, everyone know it did what it said on the tin, BUT it had to be proven in trials, not only in the U.K. but also in Europe and the USA. There was further good news today and the share price has moves swiftly up. After three years,I am only just in profit but I feel sure there is much further to go. This is not a plug for AGL, but a reality check for frustrated VRS holders. I am as certain as can be that VRS will be a gold mine for me, BUT even though you know that the technology works, companies will need to be certain that it works on their application. That can require a few tweaks. Personally, I am not looking at the share price on an hourly basis, I belive that it is good investment and will come good, probably quicker than I think.
02/6/2017
17:38
rogerbridge: Yes SG, Epson in particular caught my eye for the ink side. Samsung and others spent a great deal of money on one company and ended up in a blind alley. There are some global companies who would be in touch with the NGI and Nanene has been certified and ready to go. As I have said before, once bitten, twice shy a lot of CTO's have egg on their faces and there will be more than one very unhappy CFO. CTO's will not want to make the same mistake twice, it's too risky for their career, let alone the company that they work for. There will be NDA's and a lot of testing and proving to do, but VRS have the genuine article, Nanene or Inks. Why would any company want to go elsewhere? There have been too many short term investors here and it may be several months before the blue touch paper is lit up. But then, what a beautiful site as VRS share price goes balistic. Well that's what I hope for, we shall see.
17/5/2017
16:51
rogerbridge: Let us not forget, VRS is not a one trick pony, thate are other companies in the group with good prospects, not exciting, but stable and possibly with new offerings out soon. Some companies that are always promising but never delivering have far a higher capitalisation than VRS. I believe Nanene and inks will be in products before too long,but it takes time to test and test again. One good rns could double the share price in a few days, the question I believe is when not if. I am not concerned with short term fluctuations in price, or short term traders bent on trying to manipulate the share price. You are either believe the VRS team or do not bother to invest.
16/5/2017
19:32
superg1: Rhe I was having a conversation about 'investors' on BBs earlier today. Many are not investors but just short term share price chasers. I'm quite happy to do that with some but then I call it trading with little long term interest in the company and rarely post. Equally I know some on here are long term investors and they have build up positions in excess of 250k shares and others over 500k shares. Now with those amount you can more or less be called a potential long term investor as if you tried to offload those on bad news you are not going to get a good price. Then if you had managed to cash in over time on the drift then on good news you may want them back but the same problem exists. So for me when I like something I buy and hold as it's pointless me trying to guess on news and whether stock will be available. Currently it's still over 100% from a few months back and over 40% up since the fund raise. I have thoughts of a much higher share price based on the research and the leads VRS have, so I'll be hanging on for that but have an open target as one good turn could create another. I've watched companies go to ridiculous levels due to be signed up with 1 company and watched one well known AIM soar on the back of a deal with someone VRS are in an NDA with. So if such circs come about then anyone trying to get 250k shares or 500k shares plus is going to struggle and be battling with others looking to land up. Clearly there is enough churn/supply at the moment probably down to profit taking at this time and it may continue for weeks. However if big news come when there is no supply or big news ends such a supply then the share price would take off. When you get good prospects on the back of such news funds come in and sit sucking up all the trader sells. We've all seen it before. That's the gamble, go in when the share price is low while others are fearful, or wait and chase the trend with more security. Someone used Samsung as an example over on III. So if they signed with Samsung or Apple (just using the big names) what then. Is it a case of waiting to see if Apple or Samsung throw in a big order or take a stake in the company. Just throwing the thoughts out there. As mentioned I watched the herd nutters wet their pants as they have heard company A is talking to their Aim company and the BBs go ramptastic. VRS is chatting to 50-100 companies in NDAs many of which are very large companies. They in the main have approached VRS. Who was that company adding something to coke (tomato extract) chatting to coke, claims of factory staff with shares in tears as they were all going to be rich. PXS or something like that. Posters can be absolutely barmy at times, I have many as just seriously problematic gambling addicts and others just plain bonkers. The venom that comes out when greed turns into despair is incredible. Plenty of chat about sorting sales. They are sorting sales and the team has expanded since I last mentioned them. The last thing they need to be doing is to be making a pretty website for PIs to look at. The website doesn't create sales, the product and team do.
22/4/2017
08:42
superg1: Why spin BS Well the key people in a company are the CEO and Chair I'd say CFO but he left. The Chair and the CEO have options. The target to trigger the options is an increase in the share price at 25% over the AIM all share index. Chair options about 492,000 shares and a price of 20p CEO 323k shares at 33p. Share price 185p. So they have very handsome options based on getting the share price up.
23/11/2016
12:47
superg1: re Having a competitor in this field, such as Haydale, with only 17.01 million shares in issue and a share price of 180 -185p, compared to VRS with 105.52 shares in issue and a share price of just 11.5p makes me nervous. Haydale have a much stronger investment engine to raise funding to compete via equity release than VRS by an order of nearly 16 to 1 . Given this, I need to know just how much of different market VRS are operating in. ??? They are two different companies. One produces GNPs and the other enables them. VRs do not need an enabler in many end products neother do others. The whole market ism open to VRS,. Haydle being enablers have thei market reduced, but sit well if they remain the goo too compnay for enabling. They however have no security of supply that is obvious on the few layer level and any few layer supplier may get a better deal elsewhere and stop supplying Haydale. I get the funding thing as it's much less dilutive and totally agree but I'm here for the business view not dilition view. I fear dilution less tham others. I see dilution for gain here not to spalsh out on company jollies, bonuses and plush hotels on junk trips. Then another £3 to £5 mill down the drain most in salaries I expect VRS to dilute if they need to cash in on a money making opportunity, EG a material order for GNPs beyond current capacities that may dictate a good business sense. If Hayd come to VRS asking for high quality GNPs, if the price is right then why not? It doesn't necessarily affect them and what they want to do, it would just be a very tightly worded deal and cash in the bank. I'd do take or pay or similar, otherwise they could sod off.
23/11/2016
11:08
ridicule: SG and others. We must all be careful that our gleened knowledge of Graphene and the associated GNPs do not become so influencial that they cloud our observations on business developments in this market. The following is out in print in the public domain and no one from either Haydale or Huntsman have challenged it to my knowledge: "Ray Gibbs, chief executive of Haydale, is confident a deal will soon be signed which could potentially create a recurring revenue stream for the small cap. It could be a big prize as Huntsman is a major resin supplier to the tooling market. Gibbs believes Haydale will be asked to supply a master batch of graphine-enhanced resin. Huntsman will then be responsible for sales and marketing. We believe they want to focus on the automotive industry for the enhanced resin, but they won't tell us until a license deal is signed he says. Gibbs suggests the contract-assuming one is awarded-would involve Haydale buying resin from hHntsman, adding its magic, and then selling the enhanced resin back to the chemicals group. That implies Haydale would need to find a chunk of cash to act as working capital to fund the purchase of the raw material." There are no indications of the quantities involved or the quality/type of the graphene infusion process. Given SGs input it would not seem that it is 'top end', but these people are not stupid and I cannot accept some of the comments here suggesting or infering that they are. I think we should be focusing on why the VRS NOMAD is not achieving the same level of publicity for VRS and ensuring the market understands where VRS sit in relations to competitors such as Haydale. If this was made clear and was as positive as SG believes, the share price would start to move. I for one, as an investor in VRS and not Haydale, would like to see far more clarity on where VRS sit. I hope there will be some clarification in 6 days time when the latest results are declared. Having a competitor in this field, such as Haydale, with only 17.01 million shares in issue and a share price of 180 -185p, compared to VRS with 105.52 shares in issue and a share price of just 11.5p makes me nervous. Haydale have a much stronger investment engine to raise funding to compete via equity release than VRS by an order of nearly 16 to 1 . Given this, I need to know just how much of different market VRS are operating in.
Versarien share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170819 05:29:35